Close this search box.

Smart to lead Actym as CEO

ARTICLE | Management Tracks

Plus: Ramanayake joins CureVac and updates from Oruka, Madrigal and AusBiotech

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

April 25, 2024 12:53 AM UTC

Actym Therapeutics Inc. named Thomas Smart as CEO. Smart was CEO and chair at Gravitas Therapeutics Inc., a company he founded. Actym is delivering immunomodulatory payload combinations to solid tumors using a modified bacterial vector.

CureVac N.V. (NASDAQ:CVAC) hired Thaminda Ramanayake as CBO. Ramanayake joins CureVac from Affini-T Therapeutics Inc., where he also held the CBO role. Before that he was VP, global head of business development in oncology at Sanofi (Euronext:SAN; NASDAQ:SNY)…